Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Spencer

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Stem Cell Research & Therapy|July 16, 2014
Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic modelsMathew Blurton-Jones, Brian Spencer, Sara Michael, et al.
Plos One|April 20, 2012
Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathyAnna E Cartier, Kiren Ubhi, Brian Spencer, et al.
Acta Neuropathologica Communications|January 15, 2017
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2015
HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disordersJerel Fields, Wilmar Dumaop, Simona Eleuteri, et al.
Plos One|November 25, 2010
Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicityDiana L Price, Edward Rockenstein, Kiren Ubhi, et al.
Plos One|April 30, 2013
TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's diseaseAndreas Bender, Paula Desplats, Brian Spencer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2018
Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid diseaseElena S Klimtchuk, Tatiana Prokaeva, Nicholas M Frame, et al.
Experimental & Molecular Medicine|February 17, 2021
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cellsChangyoun Kim, Somin Kwon, Michiyo Iba, et al.
Journal of Neurochemistry|August 29, 2018
Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapyJerel Adam Fields, Brian Spencer, Mary Swinton, et al.
Neuron|September 10, 2013
Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's diseaseKurt M Lucin, Caitlin E O'Brien, Gregor Bieri, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Stem Cell Research & Therapy|July 16, 2014
Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic modelsMathew Blurton-Jones, Brian Spencer, Sara Michael, et al.
Plos One|April 20, 2012
Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathyAnna E Cartier, Kiren Ubhi, Brian Spencer, et al.
Acta Neuropathologica Communications|January 15, 2017
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2015
HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disordersJerel Fields, Wilmar Dumaop, Simona Eleuteri, et al.
Plos One|November 25, 2010
Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicityDiana L Price, Edward Rockenstein, Kiren Ubhi, et al.
Plos One|April 30, 2013
TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's diseaseAndreas Bender, Paula Desplats, Brian Spencer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2018
Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid diseaseElena S Klimtchuk, Tatiana Prokaeva, Nicholas M Frame, et al.
Experimental & Molecular Medicine|February 17, 2021
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cellsChangyoun Kim, Somin Kwon, Michiyo Iba, et al.
Journal of Neurochemistry|August 29, 2018
Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapyJerel Adam Fields, Brian Spencer, Mary Swinton, et al.
Neuron|September 10, 2013
Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's diseaseKurt M Lucin, Caitlin E O'Brien, Gregor Bieri, et al.
Pageof 12